A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee

• Status: Terminated
• Trial end date: 2007-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary aim is to assess if PF-00592379 is able to reduce pain in patients with osteoarthritis of the knee.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Oxycodone

Criteria

Inclusion Criteria:

• Male or female of any race

• Between the ages of 18 and 75 years

• Knee Pain due to osteoarthritis

Exclusion Criteria:

• Pregnant

• Participation in a clinical trial for an investigational drug and/or agent within 30 days prior to baseline

• History of malignancy, convulsions, chronic infections, arthroscopy of the worst knee within the past year